BriaCell Therapeutics Corp. (BCTX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Total Current Assets | 25.39M | 32.18M | 11.35M | 27.4M | 20.43M | 10.56M | 11.44M | 5.07M | 7.56M | 15.78M | 25.31M | 35.99M | 40.2M | 45.36M | 51.88M | 54.31M | 59.33M | 61.35M | 69.13M | 72.23M |
| Cash & Short-Term Investments | 22.8M | 29.9M | 10.18M | 24.56M | 17.22M | 7.39M | 8.06M | 1.2M | 1.28M | 8.39M | 18.76M | 28.38M | 38.38M | 44.78M | 50.83M | 52.63M | 57.15M | 60.93M | 68.6M | 71.57M |
| Cash Only | 6.88M | 29.9M | 2.71M | 14.43M | 17.22M | 7.39M | 8.06M | 1.2M | 1.28M | 8.39M | 18.76M | 28.38M | 38.38M | 44.78M | 50.83M | 52.63M | 57.15M | 60.93M | 68.6M | 71.57M |
| Short-Term Investments | 15.92M | 0 | 7.46M | 10.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 3.09M | 1.17M | 776.54K | 3.21M | 3.17M | 3.38M | 1.9M | 20.82K | 40.52K | 29.43K | 958.56K | 20.29K | 11.93K | 40.31K | 30.91K | 18.65K | 34.5K | 23.89K | 15.71K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.59M | -810.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 1.68M | 1.42M | 1.73M | 2.37M | 3.06M | 3.24M | 3.06M | 3.08M | 920.05K | 657.42K | 292.95K | 287.23K | 298.22K | 297.68K | 307.46K | 295.41K | 300.51K | 302.2K | 298.92K | 306.96K |
| Property, Plant & Equipment | 349K | 251.14K | 273.98K | 408.1K | 441.64K | 504.77K | 508.55K | 538.87K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 173.07K | 176.89K | 180.71K | 253.71K | 188.34K | 279.34K | 272.87K | 277.36K | 280.32K | 278.82K | 292.95K | 287.23K | 296.51K | 296.3K | 307.46K | 295.4K | 300.51K | 302.2K | 298.92K | 306.95K |
| Long-Term Investments | 0 | 789.97K | 554.45K | 720.84K | 686.17K | 669.68K | 587.39K | 580.96K | 641.8K | 378.59K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.16M | 197.57K | 717.51K | 986.51K | 1.75M | 1.79M | 1.69M | 1.68M | 0 | 0 | 0 | 0 | 1.71K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 27.07M | 33.59M | 13.08M | 29.77M | 23.49M | 13.8M | 14.5M | 8.15M | 8.48M | 16.44M | 25.6M | 36.28M | 40.49M | 45.66M | 52.19M | 54.6M | 59.63M | 61.66M | 69.43M | 72.54M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 15.25% | 143.44% | -9.81% | 265.14% | 177.1% | -16.06% | -43.37% | -77.53% | -79.07% | -63.99% | -50.95% | -33.56% | -32.09% | -25.94% | -24.83% | -24.73% | 183.28% | 13378.05% | 15229.24% | 13787.95% |
| Total Current Liabilities | 3.59M | 3.19M | 3.32M | 5.47M | 5.98M | 7.71M | 6.94M | 10.36M | 9.23M | 5.27M | 1.44M | 2.41M | 1.88M | 896.1K | 1.32M | 1.21M | 470.09K | 768.46K | 533.27K | 695.86K |
| Accounts Payable | 0 | 1.88M | 2.13M | 4.51M | 4.53M | 7.37M | 5.89M | 9.95M | 8.78M | 4.99M | 596.55K | 1.5M | 1.36M | 778.53K | 1.07M | 594.14K | 0 | 0 | 0 | 267.59K |
| Days Payables Outstanding | - | 6.79K | 11.58K | 11.42K | 19.29K | 23.43K | 27.91K | 11.99K | 164.83K | 66.87K | 25.84K | 34.04K | 24.9K | 22.05K | 20.6K | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.59M | 0 | 0 | 954.58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 470.09K | 768.46K | 533.27K | 0 |
| Current Ratio | 7.07x | 10.10x | 3.42x | 5.01x | 3.41x | 1.37x | 1.65x | 0.49x | 0.82x | 2.99x | 17.59x | 14.96x | 21.33x | 50.62x | 39.24x | 45.00x | 126.20x | 79.84x | 129.63x | 103.81x |
| Quick Ratio | 7.07x | 10.10x | 3.42x | 5.01x | 3.41x | 1.37x | 1.65x | 0.49x | 0.82x | 2.99x | 17.59x | 14.96x | 21.33x | 50.62x | 39.24x | 45.00x | 126.20x | 79.84x | 129.63x | 103.81x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 71.85K | 195.1K | 406.87K | 464.27K | 1.01M | 1.34M | 2.38M | 1.52M | 7.76M | 22.35M | 20.7M | 38.92M | 46.64M | 46.48M | 36.84M | 40.15M | 357.29K | 315.55K | 411.9K | 37.26M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.33K | 32.48K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 71.85K | 195.1K | 406.87K | 464.27K | 1.01M | 1.34M | 2.38M | 1.52M | 7.76M | 22.35M | 20.7M | 38.92M | 46.64M | 46.48M | 36.84M | 40.15M | 357.29K | 315.55K | 378.57K | 37.23M |
| Total Liabilities | 3.66M | 3.38M | 3.72M | 5.93M | 6.99M | 9.04M | 9.33M | 11.88M | 16.99M | 27.62M | 22.14M | 41.32M | 48.52M | 47.37M | 38.16M | 41.36M | 827.38K | 1.08M | 945.18K | 37.96M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.33K | 32.48K |
| Net Debt | -6.88M | -29.9M | -2.71M | -14.43M | -17.22M | -7.39M | -8.06M | -1.2M | -1.28M | -8.39M | -18.76M | -28.38M | -38.38M | -44.78M | -50.83M | -52.63M | -57.15M | -60.93M | -68.57M | -71.54M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -162.51x | - | - | - | - | - | - | - | - | - | - | - | - | - | -27740.03x | - |
| Total Equity | 22.76M | 30.03M | 9.35M | 23.83M | 16.5M | 4.76M | 5.17M | -3.73M | -8.52M | -11.18M | 3.46M | -5.04M | -8.03M | -1.71M | 14.03M | 13.25M | 58.8M | 60.57M | 68.48M | 34.58M |
| Equity Growth % | 37.96% | 531.37% | 80.91% | 739.42% | 293.69% | 142.54% | 49.4% | 26.11% | -6.1% | -553.16% | -75.34% | -138.08% | -113.65% | -102.83% | -79.52% | -61.7% | 325.5% | 1768.27% | 2132.43% | 1061.33% |
| Book Value per Share | 3.14 | 10.71 | 4.96 | 12.65 | 8.83 | 1.76 | 2.91 | -3.10 | -7.99 | -10.49 | 3.11 | -4.73 | -7.76 | -1.65 | 13.56 | 14.59 | 57.43 | 49.37 | 67.41 | 114.78 |
| Total Shareholders' Equity | 23.41M | 30.73M | 9.98M | 24.58M | 17.15M | 5.31M | 5.63M | -3.31M | -8.15M | -10.85M | 3.74M | -5.04M | -8.03M | -1.71M | 14.03M | 13.25M | 58.8M | 60.57M | 68.48M | 34.58M |
| Common Stock | 0 | 116.39M | 101.74M | 139.88M | 129.9M | 125.94M | 114.2M | 100.18M | 95.1M | 93.54M | 95.67M | 92.94M | 89.36M | 87.67M | 89.02M | 84.12M | 71.68M | 68.49M | 68.44M | 68.45M |
| Retained Earnings | -134.34M | -126.39M | -119.95M | -153.65M | -143.22M | -143.75M | -127.01M | -118.61M | -115.1M | -115.52M | -102.63M | -107.71M | -106.59M | -98.03M | -83.42M | -77.4M | -35.4M | -28.9M | -22.43M | -36.42M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -138.68K | 40.72M | -138.68K | 38.36M | -191.6K | -204.39K | -193.05K | -192.52K | -189.51K | -186.41K | -190.66K | -185.22K | -188.95K | -185.37K | -188.24K | -177.86K | -177.98K | -176.11K | -171.45K | -173.32K |
| Minority Interest | -649.1K | -698.28K | -627.56K | -751.79K | -654.96K | -554.19K | -458.83K | -419.97K | -366.14K | -328.54K | -281.99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |